TD Asset Management launches new ETF focused on the growing global healthcare sector
TORONTO, April 14, 2021 /CNW/ - Today, TD Asset Management Inc. (TDAM) announced the launch of TD Global Healthcare Leaders Index ETF (Ticker Symbol: "TDOC"), a new low-cost solution providing investors with global exposure to the growing healthcare industry.
"With the realities we've all experienced as a result of COVID-19, the global healthcare industry has never been more important. That's why we're proud to launch the TD Global Healthcare Leaders Index ETF, which provides unitholders with the opportunity to invest in companies that are on the forefront of healthcare innovation," said Rob Vanderhooft, Chief Investment Officer, TDAM and Senior Vice President, TD Bank Group. "The sector is already one of the largest in the S&P 500 Index and continues to expand globally. With changes in demographics and the impact of global health events, significant investments in medicine, equipment and services are necessary to help meet these changes," added Vanderhooft. "This new ETF offers a convenient and low-cost way to participate in this growth, while investing in companies dedicated to supporting progress in healthcare and our collective well-being over the long-term."
TD Global Healthcare Leaders Index ETF seeks to track the performance of a global equity index which measures the investment return of global issuers related to healthcare. Currently, TD Global Healthcare Leaders Index ETF aims to track the Solactive Global Healthcare Leaders Index (CA NTR), which reflects the securities performance of global large and mid-capitalization issuers that are related to healthcare.
Features of this TD ETF include:
Global Exposure: TD Global Healthcare Leaders Index ETF invests in companies across multiple countries that are at the forefront of healthcare innovations, as well as technology and pharmaceuticals, healthcare equipment and life sciences tools, and service providers.
Diversified Portfolio: A cap of 2% on individual securities improves diversification compared to indexes or portfolios that overweight mega-cap pharmaceutical companies
Low Cost: A competitive management fee of 0.35% provides a low-cost option for global exposure to the attractive, growing healthcare industry
Additional information about TD Global Healthcare Leaders Index ETF, including the prospectus and ETF Facts, can be found at www.tdassetmanagement.com. Information about the complete suite of TD ETFs is also available on the TD ETF Resource Centre.